Abstract: Robust facial expression recognition in unconstrained, “in-the-wild” environments remains challenging due to significant domain shifts between training and testing distributions. Test-time ...

After nearly a decade of research and development, a Madison company is launching an innovative blood test that can detect cancers. Exact Sciences Corp., the maker of Cologuard, a home collection kit ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...

(RTTNews) - Exact Sciences Corp. (EXAS) announced the U.S. launch of Cancerguard™, its multi-cancer early detection or MCED blood test, now available as a laboratory-developed test or LDT. Cancerguard ...

Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) blood test that is now available as ...